Mark E. Stearns

3.0k total citations
73 papers, 2.6k citations indexed

About

Mark E. Stearns is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark E. Stearns has authored 73 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 30 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark E. Stearns's work include Prostate Cancer Treatment and Research (21 papers), Microtubule and mitosis dynamics (15 papers) and Protease and Inhibitor Mechanisms (13 papers). Mark E. Stearns is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Microtubule and mitosis dynamics (15 papers) and Protease and Inhibitor Mechanisms (13 papers). Mark E. Stearns collaborates with scholars based in United States, Canada and Switzerland. Mark E. Stearns's co-authors include Kenneth D. Tew, Min Wang, Min Wang, K Fudge, Min Wang, David L. Brown, M. Wang, Nathan G. Dolloff, Olimpia Meucci and Alessandro Fatatis and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Mark E. Stearns

73 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark E. Stearns 1.1k 1.1k 689 589 363 73 2.6k
Kristiina Iljin 2.1k 1.9× 767 0.7× 763 1.1× 594 1.0× 341 0.9× 56 3.1k
Carlton R. Cooper 1.0k 1.0× 1.4k 1.3× 415 0.6× 595 1.0× 285 0.8× 40 2.7k
Simone Chevalier 1.5k 1.4× 497 0.5× 445 0.6× 710 1.2× 257 0.7× 119 2.9k
Dominic Fan 2.0k 1.9× 2.0k 1.8× 755 1.1× 861 1.5× 276 0.8× 72 4.1k
Geoffrey Bartholomeusz 2.0k 1.9× 1.1k 1.0× 482 0.7× 542 0.9× 353 1.0× 45 3.1k
Noboru Kuzumaki 1.3k 1.2× 682 0.6× 301 0.4× 343 0.6× 532 1.5× 123 2.4k
Manuela Vecchi 1.5k 1.4× 1.0k 1.0× 531 0.8× 260 0.4× 351 1.0× 42 2.6k
Matilde Olivé 1.2k 1.1× 978 0.9× 444 0.6× 350 0.6× 142 0.4× 18 2.1k
Frank Hilberg 2.0k 1.8× 1.1k 1.1× 497 0.7× 1.2k 2.0× 286 0.8× 57 4.0k
Volker Ehemann 2.3k 2.1× 889 0.8× 798 1.2× 234 0.4× 452 1.2× 96 3.5k

Countries citing papers authored by Mark E. Stearns

Since Specialization
Citations

This map shows the geographic impact of Mark E. Stearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Stearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Stearns more than expected).

Fields of papers citing papers by Mark E. Stearns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Stearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Stearns. The network helps show where Mark E. Stearns may publish in the future.

Co-authorship network of co-authors of Mark E. Stearns

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Stearns. A scholar is included among the top collaborators of Mark E. Stearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Stearns. Mark E. Stearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amatangelo, Michael, Shaun M. Goodyear, Devika M. Varma, & Mark E. Stearns. (2012). c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial–mesenchymal transition and invasion in prostate cancer. Carcinogenesis. 33(10). 1965–1975. 48 indexed citations
2.
Stearns, Mark E. & Min Wang. (2011). Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors. Translational Oncology. 4(3). 147–156. 55 indexed citations
3.
Stearns, Mark E., et al.. (2010). Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies. American Journal Of Pathology. 177(6). 3169–3179. 54 indexed citations
4.
Goodyear, Shaun M., et al.. (2009). Role of the VEGFR3/VEGFD receptor axis in TGFβ1 activation of primary prostate cell lines. The Prostate. 69(9). 982–990. 8 indexed citations
5.
Wang, Min, et al.. (2009). RPS2: a novel therapeutic target in prostate cancer. Journal of Experimental & Clinical Cancer Research. 28(1). 6–6. 55 indexed citations
6.
7.
Wang, Min, et al.. (2004). Evidence for Prostate Cancer-Associated Diagnostic Marker-1. Clinical Cancer Research. 10(7). 2452–2458. 9 indexed citations
8.
9.
Stearns, Mark E., et al.. (2003). A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells. British Journal of Cancer. 88(10). 1605–1614. 11 indexed citations
10.
11.
Wang, Min, et al.. (2002). IL-10/IL-10 Receptor Signaling Regulates TIMP-1 Expression. Cancer Biology & Therapy. 1(5). 556–563. 14 indexed citations
12.
Garcia, Fernando U., et al.. (2000). Increased Cellularity of Tumor-Encased Native Vessels in Prostate Carcinoma Is a Marker for Tumor Progression. Modern Pathology. 13(7). 717–722. 5 indexed citations
13.
Liu, Xinhua, Alexander Kirschenbaum, Yao Shen, et al.. (1999). Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clinical & Experimental Metastasis. 17(8). 687–694. 141 indexed citations
14.
Stearns, Mark E., Joy L. Ware, David B. Agus, et al.. (1998). Workgroup 2: Human xenograft models of prostate cancer. The Prostate. 36(1). 56–58. 14 indexed citations
15.
Stearns, Mark E. & Min Wang. (1998). Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice. Clinical & Experimental Metastasis. 16(8). 693–702. 36 indexed citations
16.
McGarvey, Terence W. & Mark E. Stearns. (1995). Keratinocyte Growth Factor and Receptor mRNA Expression in Benign and Malignant Human Prostate. Experimental and Molecular Pathology. 63(1). 52–62. 43 indexed citations
17.
Wang, Min & Mark E. Stearns. (1991). Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. Differentiation. 48(2). 115–125. 99 indexed citations
18.
Tew, Kenneth D. & Mark E. Stearns. (1989). Estramustine—A nitrogen mustard/steroid with antimicrotubule activity. Pharmacology & Therapeutics. 43(3). 299–319. 22 indexed citations
19.
Stearns, Mark E. & Min Wang. (1987). Evidence for intermediate filaments in squirrelfish erythrophores of Holocentrus ascensionus (Rufus). Experimental Cell Research. 173(2). 395–412. 6 indexed citations
20.
Taylor, Diane Wallace, Marcela Parra, George B. Chapman, et al.. (1987). Localization of Plasmodium falciparum histidine-rich protein 1 in the erythrocyte skeleton under knobs. Molecular and Biochemical Parasitology. 25(2). 165–174. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristiina Iljin Breakdown of academic impact, for papers by Carlton R. Cooper Breakdown of academic impact, for papers by Simone Chevalier Breakdown of academic impact, for papers by Dominic Fan Breakdown of academic impact, for papers by Geoffrey Bartholomeusz Breakdown of academic impact, for papers by Noboru Kuzumaki Breakdown of academic impact, for papers by Manuela Vecchi Breakdown of academic impact, for papers by Matilde Olivé Breakdown of academic impact, for papers by Frank Hilberg Breakdown of academic impact, for papers by Volker Ehemann
Rankless by CCL
2026